Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1996
[What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?]P André, C Bal dit Sollier, M Bonneau, et al.Haemostasis|October 1, 1996
Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?P Andre, C Bal dit Sollier, M Bonneau, et al.Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.Cerebrovascular Diseases (Basel, Switzerland)|September 16, 2009
Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic strokeC Bal Dit Sollier, I Crassard, G Simoneau, et al.Atherosclerosis|June 9, 2005
Lack of association between ADH3 polymorphism, alcohol intake, risk factors and carotid intima-media thicknessP Marques-Vidal, C Bal Dit Sollier, L Drouet, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
Relative involvement of GPIb/IX-vWF axis and GPIIb/IIIa in thrombus growth at high shear rates in the guinea pigP André, P Hainaud, C Bal dit Sollier, et al.Journal of Thrombosis and Haemostasis : JTH|May 14, 2004
Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosisC Bal dit Sollier, C Kang, N Berge, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1996
Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pigP André, B Arbeille, V Drouet, et al.Thrombosis Research|February 15, 1996
Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pigC Bal dit Sollier, L Drouet, G Pignaud, et al.British Journal of Clinical Pharmacology|March 9, 2005
Paracetamol: a haemorrhagic risk factor in patients on warfarinI Mahé, N Bertrand, L Drouet, et al.Pageof 4